Literature DB >> 19082904

Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies: only in selected, high risk patients.

Mario Bazzan, Antonella Vaccarino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19082904     DOI： 10.1007/s11739-008-0209-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  9 in total

1.  High thrombosis rate after fetal loss in antiphospholipid syndrome: effective prophylaxis with aspirin.

Authors:  D Erkan; J T Merrill; Y Yazici; L Sammaritano; J P Buyon; M D Lockshin
Journal:  Arthritis Rheum       Date:  2001-06

2.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).

Authors:  S Miyakis; M D Lockshin; T Atsumi; D W Branch; R L Brey; R Cervera; R H W M Derksen; P G DE Groot; T Koike; P L Meroni; G Reber; Y Shoenfeld; A Tincani; P G Vlachoyiannopoulos; S A Krilis
Journal:  J Thromb Haemost       Date:  2006-02       Impact factor: 5.824

3.  Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? Yes (in some cases).

Authors:  Maria Gerosa; Cecilia Chighizola; Pier Luigi Meroni
Journal:  Intern Emerg Med       Date:  2008-07-01       Impact factor: 3.397

4.  Aspirin in asymptomatic patients with confirmed positivity of antiphospholipid antibodies? No.

Authors:  Guido Finazzi
Journal:  Intern Emerg Med       Date:  2008-06-25       Impact factor: 3.397

5.  Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients.

Authors:  N M Shah; M A Khamashta; T Atsumi; G R Hughes
Journal:  Lupus       Date:  1998       Impact factor: 2.911

6.  A prospective study of antibodies to beta2-glycoprotein I and prothrombin, and risk of thrombosis.

Authors:  R Forastiero; M Martinuzzo; G Pombo; D Puente; A Rossi; L Celebrin; S Bonaccorso; L Aversa
Journal:  J Thromb Haemost       Date:  2005-06       Impact factor: 5.824

7.  Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals.

Authors:  José A Girón-González; Enrique García del Río; Carmen Rodríguez; Javier Rodríguez-Martorell; Ascensión Serrano
Journal:  J Rheumatol       Date:  2004-08       Impact factor: 4.666

8.  Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals.

Authors:  Doruk Erkan; Melanie J Harrison; Roger Levy; Margaret Peterson; Michelle Petri; Lisa Sammaritano; Aynur Unalp-Arida; Veronica Vilela; Yusuf Yazici; Michael D Lockshin
Journal:  Arthritis Rheum       Date:  2007-07

9.  Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus.

Authors:  E N Harris; A E Gharavi; M L Boey; B M Patel; C G Mackworth-Young; S Loizou; G R Hughes
Journal:  Lancet       Date:  1983-11-26       Impact factor: 79.321
  9 in total
  2 in total

1.  The "antiphospholipid triangle" in an asymptomatic patient: a case report.

Authors:  Antonella Tufano; Anna Guida; Anna Maria Cerbone; Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2010-08-19       Impact factor: 3.397

2.  Systemic lupus erythematosus and thrombosis.

Authors:  Mario Bazzan; Antonella Vaccarino; Fabio Marletto
Journal:  Thromb J       Date:  2015-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.